Brookdale Senior Living Inc. (BKD)
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.
- Symbol
- BKD
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Market cap
- $2.67B
- 52 week range
- 7.97 - 17.09
Valuation
- Share price
- $11.17 (close of 2026-09-23)
- P/E (TTM)
- -18.93x
- Price to book
- -96.57x
- Price to free cash flow
- 112.44x
- Enterprise value
- $7.79B
- Book value per share
- $-0.12
Price performance
| Period | Change |
|---|
| 1 day | -1.85% |
| 5 days | -5.74% |
| 1 month | -5.34% |
| 3 months | -19.29% |
| 6 months | -19.58% |
| Year to date | +3.52% |
| 1 year | +33.77% |
| 3 years | +161.59% |
| 5 years | +79.29% |
| 10 years | -37.07% |
| All time | -56.08% |
Profitability and growth
- Return on equity
- 605.60%
- Return on invested capital
- 0.26%
- Return on assets
- -4.41%
- Return on capital employed
- 0.25%
- Gross margin
- 26.22%
- Net margin
- -8.22%
- EBITDA margin
- 12.02%
- Revenue growth
- 2.19%
- Net income growth
- -30.09%
- Free cash flow growth
- 147.06%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 0.89%
- Current ratio
- 1.14x
- Net debt to EBITDA
- 11.91x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $3.19B
- Cost of revenue
- $2.99B
- Gross profit
- $837.55M
- EBITDA
- $383.80M
- Net income
- $-262.69M
- Earnings per share
- $-1.12
- Shares outstanding
- 235.18M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2025-12-31 | $3.19B | $837.55M | $-262.69M | $-1.12 |
| 2024-12-31 | $3.13B | $799.31M | $-201.94M | $-0.89 |
| 2023-12-31 | $3.02B | $746.70M | $-189.01M | $-0.84 |
| 2022-12-31 | $2.83B | $594.41M | $-238.43M | $-1.25 |
| 2021-12-31 | $2.76B | $500.95M | $-99.29M | $-0.54 |
| 2020-12-31 | $3.54B | $797.15M | $82.02M | $0.45 |
| 2019-12-31 | $4.06B | $876.54M | $-267.93M | $-1.44 |
| 2018-12-31 | $4.53B | $1.07B | $-528.26M | $-2.82 |
| 2017-12-31 | $4.75B | $1.25B | $-571.42M | $-3.07 |
| 2016-12-31 | $4.98B | $1.44B | $-404.40M | $-2.18 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2025-12-31 | 26.22% | -8.22% | 605.60% | 0.26% |
| 2024-12-31 | 25.57% | -6.46% | -94.40% | 0.75% |
| 2023-12-31 | 24.76% | -6.27% | -46.65% | 0.20% |
| 2022-12-31 | 21.04% | -8.44% | -40.82% | -0.81% |
| 2021-12-31 | 18.16% | -3.60% | -14.19% | -3.74% |
| 2020-12-31 | 22.52% | 2.32% | 10.22% | -1.67% |
| 2019-12-31 | 21.61% | -6.60% | -38.35% | -0.67% |
| 2018-12-31 | 23.57% | -11.66% | -51.87% | -10.61% |
| 2017-12-31 | 26.41% | -12.04% | -37.34% | -4.90% |
| 2016-12-31 | 28.93% | -8.13% | -19.46% | -0.57% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2025-12-31 | $279.12M | $4.22B |
| 2024-12-31 | $308.93M | $4.02B |
| 2023-12-31 | $277.97M | $3.66B |
| 2022-12-31 | $398.85M | $3.78B |
| 2021-12-31 | $347.03M | $3.78B |
| 2020-12-31 | $380.42M | $3.85B |
| 2019-12-31 | $240.23M | $3.22B |
| 2018-12-31 | $398.27M | $3.35B |
| 2017-12-31 | $222.65M | $3.38B |
| 2016-12-31 | $216.40M | $3.41B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2025-12-31 | $16.50M | $11.94M |
| 2024-12-31 | $-35.07M | $14.18M |
| 2023-12-31 | $-70.28M | $11.98M |
| 2022-12-31 | $-193.64M | $14.47M |
| 2021-12-31 | $-271.29M | $16.27M |
| 2020-12-31 | $19.78M | $20.75M |
| 2019-12-31 | $-87.68M | $23.03M |
| 2018-12-31 | $-21.51M | $26.07M |
| 2017-12-31 | $164.47M | $27.83M |
| 2016-12-31 | $40.00M | $32.28M |
Dividend history
- Most recent payment
- 2008-10-08
| Payment date | Dividend per share |
|---|
| 2008-10-08 | $0.25 |
| 2008-07-02 | $0.25 |
| 2008-03-27 | $0.25 |
| 2007-12-27 | $0.50 |
| 2007-09-26 | $0.50 |
| 2007-06-27 | $0.50 |
| 2007-03-28 | $0.45 |
| 2006-12-27 | $0.45 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-05
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-08-10 | Jun/2026 | - |
| 2026-05-06 | - | - |
| 2026-02-18 | - | - |
| 2025-11-06 | - | - |
| 2025-08-06 | - | - |
| 2025-05-06 | - | - |
| 2025-05-05 | - | - |
| 2025-02-18 | - | - |
Filings and sources
- Company website
- brookdale.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Vertex Pharmaceuticals Inc (VRTX) · Regeneron Pharmaceuticals, Inc. (REGN) · Moderna, Inc. (MRNA) · Incyte Corp (INCY) · Bio-Techne Corp (TECH)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades